Identifying patients at risk for augmented renal clearance in the ICU - limitations and challenges

por Carlier, Mieke, De Waele, Jan J
Publicado 2013

Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?

por De Waele, Jan J, Carlier, Mieke
Publicado 2014

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended...

por Carlier, Mieke, Carrette, Sofie, Roberts, Jason A, Stove, Veronique, Verstraete, Alain, Hoste, Eric, Depuydt, Pieter, Decruyenaere, Johan, Lipman, Jeffrey, Wallis, Steven C, De Waele, Jan J
Publicado 2013